Clovis Oncology, Inc.

CIK 1466301 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Clovis Oncology, Inc..

Recent SEC filings

FiledFormAccession number
Jul 17, 2023EFFECT9999999995-23-002102
Jul 11, 2023S-8 POS0001193125-23-185189
Jul 11, 2023S-8 POS0001193125-23-185194
Jul 11, 2023S-8 POS0001193125-23-185182
Jul 11, 20238-K0001193125-23-185076
Jul 11, 2023S-8 POS0001193125-23-185184
Jul 11, 2023POS AM0001193125-23-185162
Jul 11, 2023S-8 POS0001193125-23-185177
Jul 11, 2023S-8 POS0001193125-23-185183
Jul 11, 2023S-8 POS0001193125-23-185170
Jul 11, 202315-12G0001193125-23-185198
Jul 11, 2023S-8 POS0001193125-23-185167
Jul 11, 2023S-8 POS0001193125-23-185173
Jul 11, 2023S-8 POS0001193125-23-185175
Jul 11, 2023S-8 POS0001193125-23-185172
Jun 30, 20238-K0001193125-23-180576
Jun 2, 20238-K0001193125-23-159927
May 3, 20238-K0001193125-23-133464
May 1, 20238-K0001193125-23-130464
Apr 14, 20238-K0001193125-23-101292
Apr 6, 20238-K0001193125-23-094018
Mar 31, 20238-K0001193125-23-086545
Mar 2, 20238-K0001193125-23-057313
Feb 16, 20238-K0001193125-23-041114
Feb 13, 20238-K0001193125-23-032941